Prevent kidney stones with natural fruit extract

Image
ANI Washington
Last Updated : Aug 09 2016 | 12:57 PM IST

Natural fruit extract can dissolve the most common component of human kidney stones- calcium oxalate crystals.

The findings of the study conducted by University of Houston could lead to the first advance in the treatment of calcium oxalate stones in 30 years.

The work offers the first evidence that the compound hydroxycitrate (HCA) is an effective inhibitor of calcium oxalate crystal growth that, under certain conditions, is actually able to dissolve these crystals.

According to lead author Jeffrey Rimer, the findings are the result of a combination of experimental studies, computational studies and human studies.

Preventive treatment has not changed much over the last three decades. Doctors tell patients who are at risk of developing stones to drink lots of water and avoid foods rich in oxalate, such as rhubarb, okra, spinach and almonds. They often recommend taking citrate (CA), in the form of potassium citrate, a supplement that can slow crystal growth, but some people are unable to tolerate the side effects.

The project grew out of preliminary work done by collaborator John Asplin who suggested HCA as a possible treatment.

HCA is chemically similar to CA and is also available as a dietary supplement.

"HCA shows promise as a potential therapy to prevent kidney stones. HCA may be preferred as a therapy over CA (potassium citrate)," wrote the researchers.

The head-to-head studies of CA and HCA determined that while both compounds inhibit the growth of calcium oxalate crystals, HCA was more potent and displayed unique qualities that are advantageous for the development of new therapies.

While Rimer said the research established the groundwork to design an effective drug, questions remain as long-term safety, dosage and additional human trials are needed.

"But our initial findings are very promising. If it works in vivo, similar to our trials in the laboratory, HCA has the potential to reduce the incidence rate of people with chronic kidney stone disease," he said.

The study has been published in the online edition of Nature.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Aug 09 2016 | 12:57 PM IST

Next Story